Profile data is unavailable for this security.
About the company
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
- Revenue in USD (TTM)1.53bn
- Net income in USD207.70m
- Incorporated1996
- Employees2.20k
- LocationMasimo Corp52 DiscoveryIRVINE 92618United StatesUSA
- Phone+1 (949) 297-7000
- Fax+1 (949) 297-7499
- Websitehttps://www.masimo.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teleflex Inc | 2.39bn | 58.53m | 5.43bn | 15.50k | 99.15 | 1.74 | 23.00 | 2.27 | 1.24 | -20.56 | 53.59 | 70.70 | 0.341 | 2.23 | 5.95 | 154,489.00 | 0.8335 | 3.12 | 0.9266 | 3.43 | 53.13 | 57.05 | 2.44 | 10.06 | 2.01 | 2.73 | 0.4581 | 28.48 | 17.25 | -4.72 | 2.34 | -29.49 | 0.9821 | 0.00 |
| Caris Life Sciences Inc | -100.00bn | -100.00bn | 5.84bn | -- | -- | 12.18 | -- | -- | -- | -- | -- | 1.70 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 9.36 | -- | 0.4404 | -- | 34.67 | -- | 18.22 | -- | -- | -- |
| Avantor Inc | 6.55bn | -530.20m | 6.01bn | 13.50k | -- | 1.08 | -- | 0.9171 | -0.7775 | -0.7775 | 9.62 | 8.16 | 0.5481 | 5.70 | 6.21 | 485,348.20 | -4.44 | 2.78 | -5.17 | 3.18 | 32.65 | 33.77 | -8.09 | 5.00 | 1.18 | 3.62 | 0.4149 | 0.00 | -3.41 | 0.4913 | -174.52 | -- | 15.90 | -- |
| Bruker Corp | 3.44bn | -22.50m | 6.06bn | 11.09k | -- | 2.47 | 30.44 | 1.76 | -0.1485 | -0.1485 | 22.63 | 16.15 | 0.5705 | 1.64 | 5.22 | 310,013.50 | -0.1212 | 5.07 | -0.1553 | 6.76 | 47.13 | 49.70 | -0.2124 | 7.56 | 0.8553 | 9.30 | 0.4268 | 13.19 | 2.08 | 11.57 | -119.89 | -- | 4.34 | 4.56 |
| Glaukos Corp | 507.44m | -187.69m | 7.03bn | 1.09k | -- | 10.62 | -- | 13.86 | -3.27 | -3.27 | 8.87 | 11.41 | 0.5432 | 1.84 | 5.99 | 463,840.90 | -20.09 | -12.56 | -22.19 | -13.55 | 77.97 | 76.60 | -36.99 | -34.64 | 4.06 | -- | 0.094 | -- | 32.33 | 17.67 | -28.23 | -- | 28.47 | -- |
| Repligen Corp | 738.26m | 48.89m | 7.04bn | 2.00k | 144.59 | 3.34 | 55.15 | 9.54 | 0.8643 | 0.8643 | 13.05 | 37.39 | 0.2555 | 2.23 | 5.04 | 369,128.00 | 1.69 | 2.88 | 1.77 | 3.20 | 52.65 | 53.58 | 6.62 | 10.73 | 7.12 | -- | 0.2047 | 0.00 | 16.36 | 15.05 | 291.64 | -3.99 | -0.4706 | -- |
| Bio Rad Laboratories Inc | 2.58bn | 759.90m | 7.49bn | 7.45k | 10.02 | 1.01 | 8.10 | 2.90 | 27.91 | 27.91 | 94.69 | 276.16 | 0.2591 | 1.65 | 5.66 | 346,738.30 | 7.62 | -1.69 | 8.02 | -1.77 | 52.01 | 54.52 | 29.42 | -8.08 | 4.19 | -- | 0.139 | -- | 0.6507 | 0.2935 | 141.20 | -27.58 | 7.74 | -- |
| Masimo Corp | 1.53bn | 207.70m | 9.16bn | 2.20k | 45.25 | 12.67 | 37.16 | 6.00 | 3.88 | -2.77 | 28.42 | 13.84 | 0.7062 | 1.39 | 4.42 | 694,045.40 | 9.61 | 5.65 | 12.45 | 6.99 | 61.90 | 58.51 | 13.60 | 9.43 | 1.47 | 8.39 | 0.421 | 0.00 | 9.44 | 5.95 | 1,182.10 | -2.87 | -20.94 | -- |
| Henry Schein Inc | 13.18bn | 398.00m | 9.33bn | 25.00k | 24.88 | 2.90 | 13.00 | 0.7079 | 3.27 | 3.27 | 108.32 | 28.03 | 1.23 | 4.76 | 8.42 | 527,360.00 | 3.80 | 5.06 | 6.56 | 8.59 | 31.14 | 30.81 | 3.09 | 3.79 | 0.7627 | 6.54 | 0.3932 | 0.00 | 4.03 | 5.43 | 2.05 | -0.2399 | 31.36 | -- |
| Baxter International Inc | 11.24bn | -900.00m | 10.13bn | 37.50k | -- | 1.65 | 125.07 | 0.901 | -1.75 | -1.87 | 21.89 | 11.92 | 0.4906 | 3.64 | 6.14 | 299,840.00 | -3.93 | -2.30 | -4.96 | -2.83 | 30.68 | 36.76 | -8.00 | -5.74 | 1.56 | 2.67 | 0.6083 | -- | 5.72 | -0.7461 | -167.06 | -- | -6.27 | -11.45 |
| Revvity Inc | 2.86bn | 239.88m | 10.69bn | 11.00k | 46.14 | 1.48 | 16.56 | 3.74 | 2.07 | 2.08 | 24.49 | 64.57 | 0.2326 | 3.46 | 4.15 | 259,641.00 | 1.95 | 3.23 | 2.13 | 3.58 | 54.77 | 58.48 | 8.40 | 13.58 | 1.40 | 5.01 | 0.3075 | 8.08 | 3.67 | -5.47 | -15.26 | -19.91 | -1.05 | 0.00 |
| Guardant Health Inc | 982.02m | -416.28m | 12.10bn | 2.49k | -- | -- | -- | 12.32 | -3.31 | -3.31 | 7.83 | -0.7602 | 0.5613 | 4.45 | 7.92 | 394,385.90 | -23.79 | -25.70 | -28.02 | -28.93 | 64.46 | 63.20 | -42.39 | -76.30 | 4.56 | -- | 1.07 | -- | 32.88 | 27.92 | 4.61 | -- | -2.23 | -- |
| Solventum Corp | 8.33bn | 1.56bn | 12.66bn | 20.00k | 8.23 | 2.51 | 6.19 | 1.52 | 8.87 | 8.87 | 47.48 | 29.10 | 0.5791 | 3.81 | 8.01 | 416,250.00 | 10.82 | -- | 13.58 | -- | 53.57 | 56.92 | 18.69 | 15.05 | 0.8906 | 2.05 | 0.4993 | -- | 0.8602 | 2.72 | 224.84 | 6.46 | 6.94 | -- |
| Globus Medical Inc | 2.94bn | 537.87m | 12.69bn | 6.00k | 23.84 | 2.77 | 15.55 | 4.32 | 3.93 | 3.93 | 21.44 | 33.86 | 0.5569 | 1.35 | 4.75 | 489,821.80 | 10.19 | 6.18 | 11.69 | 6.89 | 67.41 | 66.20 | 18.30 | 12.25 | 2.74 | -- | 0.0002 | 0.00 | 16.65 | 30.08 | 422.28 | 39.37 | 22.34 | -- |
Data as of Mar 02 2026. Currency figures normalised to Masimo Corp's reporting currency: US Dollar USD
58.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 6.55m | 12.19% |
| Politan Capital Management LPas of 16 Feb 2026 | 4.59m | 8.54% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 4.26m | 7.94% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 3.99m | 7.44% |
| BlackRock Investment Management (UK) Ltd.as of 31 Dec 2025 | 2.69m | 5.01% |
| Massachusetts Financial Services Co.as of 31 Dec 2025 | 2.47m | 4.60% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2025 | 2.33m | 4.34% |
| Naya Capital Management UK Ltd.as of 31 Dec 2025 | 1.56m | 2.91% |
| Westfield Capital Management Co. LPas of 31 Dec 2025 | 1.52m | 2.83% |
| SSgA Funds Management, Inc.as of 31 Dec 2025 | 1.42m | 2.64% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
